Analysis of economic and educational spillover effects in PEPFAR countries

PLoS One. 2023 Dec 29;18(12):e0289909. doi: 10.1371/journal.pone.0289909. eCollection 2023.

Abstract

The United States President's Emergency Plan for AIDS Relief (PEPFAR) has been credited with saving millions lives and helping to change the trajectory of the global human immunodeficiency virus (HIV) epidemic. This study assesses whether PEPFAR has had impacts beyond health by examining changes in five economic and educational outcomes in PEPFAR countries: the gross domestic product (GDP) per capita growth rate; the share of girls and share of boys, respectively, who are out of school; and female and male employment rates. We constructed a panel data set for 157 low- and middle-income countries between 1990 and 2018 to estimate the macroeconomic impacts of PEPFAR. Our PEPFAR group included 90 countries that had received PEPFAR support over the period. Our comparison group included 67 low- and middle-income countries that had not received any PEPFAR support or had received minimal PEPFAR support (<$1M or <$.05 per capita) between 2004 and 2018. We used differences in differences (DID) methods to estimate the program impacts on the five economic and educational outcome measures. This study finds that PEPFAR is associated with increases in the GDP per capita growth rate and educational outcomes. In some models, we find that PEPFAR is associated with reductions in male and female employment. However, these effects appear to be due to trends in the comparison group countries rather than programmatic impacts of PEPFAR. We show that these impacts are most pronounced in COP countries receiving the highest levels of PEPFAR investment.

MeSH terms

  • Educational Status
  • Female
  • Gross Domestic Product
  • HIV Infections* / epidemiology
  • Humans
  • International Cooperation
  • Male
  • Outcome Assessment, Health Care
  • United States

Grants and funding

This paper was produced with funding from Palladium International, LLC under subcontract number 217730-Brandeis-01; and Prime Contract number 2021-002516 from the Global Fund to Fight AIDS, Tuberculosis, and Malaria. Its contents are solely the responsibility of Brandeis University and do not necessarily represent the official views of Palladium or The Global Fund.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.